Stonebridge BioPharma's IPO

Stonebridge BioPharma raised a round of funding on October 16, 2015. Investors include Public.

Strongbridge Biopharma is a biopharmaceutical company focused on the development, in-licensing, acquisition and eventual commercialization of complementary product candidates across multiple franchise…

Articles about Stonebridge BioPharma's IPO: